switching from oral to injectable semaglutide For patients with #obesity, semaglutide, a glucagon-like peptide-1 receptor agonist, is approved for weight management as a once-weekly subcutaneous injection. In a previous trial, at a dose of 50 mg Oral GLP-1 Pill Delivers Injection-Like

Risk Manag ., 4 (5), 10611078

In 2025, several major studies began to connect GLP-1 therapy to healthier aging

Its not always reported in trials, but users on 2.5mg and 5mg pens often describe feeling: Cold hands and feet General chilliness despite warm environments Night-time shivering or needing more blankets Sensitivity to wind or air conditioning How to Manage Feeling Cold on Mounjaro Eat Regular, Balanced Meals Even if youre not hungry, low-calorie intake can worsen body heat loss

Drug-Phospholipid Complex-a Go Through Strategy for Enhanced Oral Bioavailability - PubMed

Studies have shown that new weight loss drugs such as Ozempic and Wegovy can reduce body weight by 10% to 20%

10.3389/fcell.2020.576988 68 JianzhongL.YoujingY.ShuhuiW.LingC.LianX.HailinT.et al (2020b)